A medical consultation is required before treatment
Novopept products are for professional and research purposes only
The patient is either receiving guideline-directed medical therapy (GDMT) for cardiovascular disease or has a documented clinical reason for not receiving it (such as a contraindication to lipid-lowering agents, antiplatelets, beta-blockers, or renin-angiotensin inhibitors) ( Documentation is required for approval) Continuation of therapy: The request is for continued treatment, and
Glutathione is available in various forms, including oral capsules, intravenous injections, and liposomal formulations, which are designed to improve absorption and bioavailability
One must have a BMI of 30 or above, or a BMI of at least 27 or above with a weight-related health condition like high blood pressure, diabetes, or high cholesterol